ARCH Venture Partners XII, L.P.

10% owner at Neumora Therapeutics, Inc. · on record since Sep 29, 2023
10% owner at Prime Medicine, Inc. · on record since Feb 20, 2024
10% owner at Rapport Therapeutics, Inc. · on record since Jun 10, 2024
10% owner at Metsera, Inc. · on record since Jan 30, 2025
Director at Metsera, Inc. · on record since Nov 14, 2025
10% owner at Seaport Therapeutics, Inc. · on record since Apr 30, 2026

Insider trading activity of ARCH Venture Partners XII, L.P.

No transactions on record for ARCH Venture Partners XII, L.P..

Track record of ARCH Venture Partners XII, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ARCH Venture Partners XII, L.P.

Co-insiders of ARCH Venture Partners XII, L.P.

ARCH Venture Fund XII, L.P.Metsera, Inc. +4
ARCH Venture Partners XII, LLCMetsera, Inc. +4
Burow KristinaMetsera, Inc. +4
CRANDELL KEITHMetsera, Inc. +4
GILLIS STEVENMetsera, Inc. +4
NELSEN ROBERTMetsera, Inc. +4
FMR LLCMetsera, Inc. +2
ARCH Venture Fund X, L.P.Neumora Therapeutics, Inc. +1
ARCH Venture Fund X Overage, L.P.Neumora Therapeutics, Inc. +1
ARCH Venture Partners X, LLCNeumora Therapeutics, Inc. +1
ARCH Venture Partners X, L.P.Neumora Therapeutics, Inc. +1
ARCH Venture Partners X Overage, L.P.Neumora Therapeutics, Inc. +1
BERNS PAUL LMetsera, Inc. +1
HEALY JAMESRapport Therapeutics, Inc. +1
PAUL STEVEN MRapport Therapeutics, Inc. +1
Pinto JoshuaMetsera, Inc. +1
Alenson CarmanPrime Medicine, Inc.
Alphabet Inc.Prime Medicine, Inc.
AMGEN INCNeumora Therapeutics, Inc.
ARCH Venture Fund VIII Overage, L.P.Neumora Therapeutics, Inc.
Arch Venture Fund VII LPNeumora Therapeutics, Inc.
ARCH Venture Fund XIII, L.P.Metsera, Inc.
ARCH Venture Partners VIII, LLCNeumora Therapeutics, Inc.
ARCH Venture Partners VII, LLCNeumora Therapeutics, Inc.
ARCH Venture Partners VII, L.P.Neumora Therapeutics, Inc.
ARCH Venture Partners XIII, LLCMetsera, Inc.
ARCH Venture Partners XIII, L.P.Metsera, Inc.
Aurora Daljit SinghNeumora Therapeutics, Inc.
Bernard Christopher WhittenMetsera, Inc.
Bredt DavidRapport Therapeutics, Inc.
Brudnick RichardPrime Medicine, Inc.
Burrell Terry-AnnRapport Therapeutics, Inc.
BYBEE CLINTONNeumora Therapeutics, Inc.
Cahill ThomasPrime Medicine, Inc.
Ceesay AbrahamRapport Therapeutics, Inc.
Chen Michael CunyuanSeaport Therapeutics, Inc.
Chung WendyPrime Medicine, Inc.
Duffield JeremyPrime Medicine, Inc.
Duncan JasonNeumora Therapeutics, Inc.
Foster-Cheek Kaye IPrime Medicine, Inc.
Fust Matthew KNeumora Therapeutics, Inc.
Galer Bradley S.Rapport Therapeutics, Inc.
GAP (Bermuda) LTDSeaport Therapeutics, Inc.
GAP Coinvestments CDA, L.P.Seaport Therapeutics, Inc.
GAP COINVESTMENTS III LLCSeaport Therapeutics, Inc.
GAP COINVESTMENTS IV LLCSeaport Therapeutics, Inc.
GAP Coinvestments V, LLCSeaport Therapeutics, Inc.
Gault CherylRapport Therapeutics, Inc.
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.Seaport Therapeutics, Inc.
GENERAL ATLANTIC GENPAR, L.P.Seaport Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →